Kiniksa Pharmaceuticals Ltd. (KNSA) - Insider Holders & Insider Ownership

List of insiders holdings for Kiniksa Pharmaceuticals Ltd.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
1BAKER BROS. ADVISORS LP
667 L.P.
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
BAKER FELIX
BAKER JULIAN
Director		2025-06-05 17:06:5129,680
2,839,604		2,869,284Form 4
2Cormorant Asset Management LP
Cormorant Global Healthcare Master Fund LP
CORMORANT PRIVATE HEALTHCARE FUND I LP
Chen Bihua
10% Owner		2019-02-14 16:14:48831,000
0		831,000Form 13G
3Cormorant Asset Management LP
Chen Bihua
Cormorant Global Healthcare GP LLC
Cormorant Global Healthcare Master Fund LP
10% Owner		2019-02-14 16:14:48831,000
0		831,000Form 13G
4BOESS CARSTEN
10% Owner		2018-05-29 19:19:09559,016
0		559,016Form 4
5Patel Sanj K
CHAIRMAN & CEO		2026-04-03 16:39:03255,082
232,603		487,685Form 4
6Paolini John F.
CHIEF MEDICAL OFFICER		2026-04-03 16:37:30123,679
0		123,679Form 4
7Tessari Eben
CHIEF STRATEGY OFFICER		2026-04-03 16:41:1891,983
0		91,983Form 4
8Moat Ross
CHIEF OPERATING OFFICER		2026-04-03 16:35:5491,109
0		91,109Form 4
9Malley Thomas
Director		2025-08-14 16:59:0312,546
71,967		84,513Form 4
10Mahoney Stephen F.
President & COO		2019-09-19 16:18:3782,000
0		82,000Form 4
11Ragosa Mark
CHIEF FINANCIAL OFFICER		2026-04-03 16:40:0979,781
0		79,781Form 4
12Megna Michael R
CHIEF ACCOUNTING OFFICER		2026-04-03 16:34:3472,540
0		72,540Form 4
13Heberlig Chris
EVP & CFO		2019-09-19 16:16:5250,000
0		50,000Form 4
14McCain Tracey L
Director		2025-06-05 16:59:3332,143
0		32,143Form 4
15Cole G Bradley
Director		2025-06-05 17:07:4132,143
0		32,143Form 4
16Pano Arian
Chief Clinical Dev. Officer		2021-09-07 17:19:2127,213
0		27,213Form 4
17Levy Richard S
Director		2026-02-04 18:20:5819,840
0		19,840Form 4
18Quart Barry D
Director		2026-02-12 16:34:4415,236
0		15,236Form 4
19Popovits Kimberly J
Director		2025-08-01 16:36:0712,546
0		12,546Form 4
20Beetham Thomas W.
EVP & Chief Legal Officer		2021-03-23 17:32:5610,142
0		10,142Form 4
21Rizvi Qasim
Chief Commercial Officer		2021-01-05 17:07:035,176
0		5,176Form 4
22Boyd Meta Cantey
Director		2024-10-08 17:08:240
0		0Form 3
23Flynn James E
Deerfield Mgmt L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Special Situations Fund L.P.
DEERFIELD PARTNERS L.P.
*Possible member of 10% group
10% Owner		2020-02-13 12:42:470
0		0Form 13G
24Biggar Stephen R
Director		2018-05-23 20:23:420
0		0Form 3